Healthtech funding in Q2 2022
European Healthtech startup funding raised during Q2 2022.
In Q2 2022, 157 European Healthtech companies closed 158 funding rounds and raised €1.9B in equity funding (excluding debt and grants), down 17.5% versus Q2 2021. France led by capital raised, and Co-Founders was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.9B
-17.5% vs Q2 2021 · excl. debt & grants
Funding rounds
158
+15.3% vs Q2 2021
Companies
157
Top country
France
Rank among sectors
#7
6.4% of sector funding
Top-10 round share
35.7%
of disclosed capital
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q2 2022 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Apr | €475M | 44 |
| May | €529M | 47 |
| Jun | €927M | 67 |
Top countries
by € raisedHealthtech — top countries by capital, Q2 2022 — interactive chart.
Data table
| Healthtech — top countries by capital, Q2 2022 | |
|---|---|
| France | €469M |
| UK | €458M |
| Germany | €239M |
| Switzerland | €194M |
| Sweden | €161M |
| Spain | €119M |
| Denmark | €68M |
| Iceland | €68M |
Stage mix
by € raisedHealthtech — stage mix, Q2 2022 — interactive chart.
Data table
| Healthtech — stage mix, Q2 2022 | |
|---|---|
| Other | €787M |
| Series B | €495M |
| Series A | €332M |
| Series C | €169M |
| Seed | €146M |
| Crowdfunding | €1.2M |
| Pre-Seed | €725k |
Exits & M&A
9 Acquisition · 1 IPO10 exits · €3.5B disclosed.
| Norgine | Acquisition | Jun 2022 | €1.8B |
| SPT Labtech | Acquisition | Jun 2022 | €757M |
| ReViral | Acquisition | Apr 2022 | €483M |
| Normax | IPO | Jun 2022 | €300M |
| PlusDental | Acquisition | May 2022 | €131M |
| Champion Health | Acquisition | May 2022 | €12M |
Top deals
largest disclosed rounds in Q2 2022| Company | Stage | Date | Amount |
|---|---|---|---|
| Imcheck Therapeutics | Other | Jun 2022 | €96M |
| OMass Therapeutics | Series B | Apr 2022 | €90M |
| Proximie | Series C | Jun 2022 | €77M |
| Owkin | Series B | Jun 2022 | €74M |
| Diabeloop | Other | Jun 2022 | €70M |
| Immunos Therapeutics | Series B | Jun 2022 | €68M |
| Tubulis Technologies | Series B | May 2022 | €60M |
| Sidekick Health | Series B | May 2022 | €52M |
| Humble | Other | Apr 2022 | €51M |
| Minoryx Therapeutics | Series C | May 2022 | €51M |
| Avi Medical | Series B | Apr 2022 | €50M |
| Cinclus Pharma | Other | May 2022 | €48M |
| Transition Bio | Series A | Jun 2022 | €47M |
| Cimeio Therapeutics | Series A | Apr 2022 | €46M |
| CARMAT | Other | Apr 2022 | €41M |
Top investors
most active in Q2 2022, by deal count- Co-Founders4 deals
- Scottish Enterprise4 deals
- ACF investors3 deals
- Brabant Development Agency3 deals
- High-Tech Gründerfonds (HTGF)3 deals
- Meltwind3 deals
- Northpond Ventures3 deals
- OCCIDENT3 deals
- Omnes Capital3 deals
- Sabadell Asabys3 deals